• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers
Get started
Sign in
Monitoring RSV: What we saw in rates of RSV hospitalization this year

Monitoring RSV: What we saw in rates of RSV hospitalization this year

by Truveta Research | Jan 13, 2023 | Research, Research Insights

Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The Truveta Research blog will surface insights shown in these Technical Reports for a broader...
Disparities in COVID-19 hospitalizations: From insights to publication

Disparities in COVID-19 hospitalizations: From insights to publication

by Truveta Research | Nov 2, 2022 | Research, Research Insights

Authors: Benjamin M. Althouse, PhD ⊕Truveta, Inc, Bellevue, WA, Information School, University of Washington, Seattle, WA Department of Biology, New Mexico State University, Las Cruces, NM, Charlotte Baker, DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Peter D. Smits, PhD...
Another round of US formula recalls: What effect does this have on the hospitalization rates of newborns and infants?

Another round of US formula recalls: What effect does this have on the hospitalization rates of newborns and infants?

by Truveta Research | Oct 31, 2022 | Research, Research Insights

On February 17, 2022, Abbott voluntarily recalled powdered formula made in a Michigan facility due to complaints of Cronobacter sakazakii and Salmonella Newport contamination [1]. Datasembly reported that baby formula was out-of-stock at 31% of stores in April 2022...
Digging deeper: Understanding more about patient subgroups with peripheral artery disease

Digging deeper: Understanding more about patient subgroups with peripheral artery disease

by Truveta Research | Oct 4, 2022 | Research, Research Insights

Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

by Truveta Research | Sep 27, 2022 | Research, Research Insights

Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
Disparities in COVID-19 hospitalizations – Part 2: Have COVID-19 hospitalization stays shortened over time?

Disparities in COVID-19 hospitalizations – Part 2: Have COVID-19 hospitalization stays shortened over time?

by Truveta Research | Sep 22, 2022 | Research, Research Insights

Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2025 
  • Rising use of robotic-assisted surgery in hysterectomy, cholecystectomy, and inguinal hernia repair
  • Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.